Catalyst Pharmaceutical
CPRX
CPRX
259 hedge funds and large institutions have $1.45B invested in Catalyst Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 82 increasing their positions, 93 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
259
Holders Change
+4
Holders Change %
+1.57%
% of All Funds
3.8%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
34
Increased
82
Reduced
93
Closed
25
Calls
$3.62M
Puts
$1.44M
Net Calls
+$2.18M
Net Calls Change
+$1.45M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$65.9M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
$25.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
$19.1M |
| 4 |
DM
Deerfield Management
New York
|
$149M |
| 5 |
Man Group
London,
United Kingdom
|
$10.8M |
